Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice

被引:85
作者
Beider, K
Nagler, A
Wald, O
Franitza, S
Dagan-Berger, M
Wald, H
Giladi, H
Brocke, S
Hanna, J
Mandelboim, O
Darash-Yahana, M
Galun, E
Peled, A
机构
[1] Hadassah Univ Hosp, Gene Therapy Inst, IL-91120 Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Dept Bone Marrow Transplant, IL-52621 Tel Hashomer, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol Oncol, IL-91010 Jerusalem, Israel
关键词
D O I
10.1182/blood-2002-10-3293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human natural killer (NK) and NK T cells play an important role in allogeneic bone marrow (BM) transplantation and graft-versus-leukemia (GVL) effect. The mechanisms by which these cells home to the BM and spleen are not well understood. Here we show that treatment of these cells with pertussis toxin and neutralizing antibodies to the chemokine receptor CXCR4 inhibited homing of the cells to the BM, but not the spleen, of NOD/SCID mice. The retention of NK and NK T cells within the spleen and BM was dependent on Galphai signaling and CXCR4 function. The chemokine receptors CXCR4 and CXCR3 are expressed predominantly on the cell surface of NK T cells. Following activation with interleukin-2 (IL-2), the levels of CXCR4 on NK and NK T cells decreased significantly. Treatment of cells with IL-2 inhibited their migration in response to CXCL12 and their homing and retention in the BM and spleen of NOD/SCID mice. In contrast to CXCR4, the expression levels of the chemokine receptor CXCR3 and the migration of cells in response to CXCL9 and CXCL10 increased after IL-2 treatment. Thus, down-regulation of CXCR4 and up-regulation of CXCR3 may direct the trafficking of cells to the site of inflammation, rather than to hematopoietic organs, and therefore may limit their alloreactive potential.
引用
收藏
页码:1951 / 1958
页数:8
相关论文
共 48 条
  • [1] The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood
    Aiuti, A
    Webb, IJ
    Bleul, C
    Springer, T
    GutierrezRamos, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) : 111 - 120
  • [2] Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production
    Baker, J
    Verneris, MR
    Ito, M
    Shizuru, JA
    Negrin, RS
    [J]. BLOOD, 2001, 97 (10) : 2923 - 2931
  • [3] The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
    Bleul, CC
    Wu, LJ
    Hoxie, JA
    Springer, TA
    Mackay, CR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1925 - 1930
  • [4] A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
    Bleul, CC
    Fuhlbrigge, RC
    Casasnovas, JM
    Aiuti, A
    Springer, TA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 1101 - 1109
  • [5] Bordignon C, 1999, HAEMATOLOGICA, V84, P1110
  • [6] LEUKOCYTE-ENDOTHELIAL CELL RECOGNITION - 3 (OR MORE) STEPS TO SPECIFICITY AND DIVERSITY
    BUTCHER, EC
    [J]. CELL, 1991, 67 (06) : 1033 - 1036
  • [7] Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
    Campbell, JJ
    Qin, SX
    Unutmaz, D
    Soler, D
    Murphy, KE
    Hodge, MR
    Wu, LJ
    Butcher, EC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (11) : 6477 - 6482
  • [8] Chemokines and the arrest of lymphocytes rolling under flow conditions
    Campbell, JJ
    Hedrick, J
    Zlotnik, A
    Siani, MA
    Thompson, DA
    Butcher, EC
    [J]. SCIENCE, 1998, 279 (5349) : 381 - 384
  • [9] Childs RW, 2002, EXP NEPHROL, V10, P227
  • [10] The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4
    DApuzzo, M
    Rolink, A
    Loetscher, M
    Hoxie, JA
    ClarkLewis, I
    Melchers, F
    Baggiolini, M
    Moser, B
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (07) : 1788 - 1793